HyperEx - Effect of skeletal muscle hypertrophy and atrophy on metabolism, metabolite exchange and the organ fate of glucose
Global skeletal muscle hypertrophy commonly has anti-obesity and antidiabetes effects, whereas global muscle atrophy worsens metabolic health. The aim of project P01 is to elucidate the underlying metabolic mechanisms using advanced methods of metabolic research. First, we will use [13C] stable isotope tracers to determine how hypertrophying and atrophying myotubes metabolize glucose, lactate, serine, valine, and taurine. We will also perform an inhibitor screen to identify metabolic enzymes or transporters that limit muscle hypertrophy. Second, we will study how hypertrophying and atrophying human leg muscles alter their metabolite uptake and release when compared to leg muscles in a size steady state. Third, we will study in myotube-adipocyte co-culture and pigs how muscle hypertrophy (and atrophy in cell culture) alters the organ/cell fate of [13C]-glucose.

Prof. Dr. Henning Wackerhage
HyperMet speaker, Principal investigator in P01 & P07
Professorship of Exercise Biology, Technical University of Munich

Dr. André Kafka
Principal investigator in P01
Clinic and Polyclinic for Internal Medicine I, TUM University Hospital

Dr. Martin Schönfelder
Postdoc in P01
Professorship of Exercise Biology, Technical University of Munich

Dr. Moritz Eggelbusch
Postdoc in P01
Professorship of Exercise Biology, Technical University of Munich

